Patent 9492535 was granted and assigned to Aimmune Therapeutics on November, 2016 by the United States Patent and Trademark Office.
The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.